Searchable abstracts of presentations at key conferences in endocrinology

ea0016p387 | Neuroendocrinology | ECE2008

Efficacy of slow release formulation of lanreotide (Somatuline Autogel® 120 mg) in patients with acromegaly: single center experience

Miljic Dragana , Nikolic-Djurovic Marina , Doknic Mirjana , Pekic Sandra , Stojanovic Marko , Popovic Vera

Somatuline Autogel® 120 mg (SATG, Ipsen, Sweeden) is a high dose sustained release aqueous gel formulation, supplied in a prefiled syringe and given by deep subcutaneous injection. The aim of this cross-sectional hospital based study, approved by the local ethical committee, was to investigate efficacy and tolerability of SATG given every 4 weeks in patients with active acromegaly.Twenty patients (9f, 11m) aged 42.9±17.8 (range 17&#1...

ea0016p390 | Neuroendocrinology | ECE2008

Cardiovascular risk factors in adult onset growth hormone deficiency (AO-GHD) without growth hormone replacement: follow-up period seven years

Djurdjevic Sandra Pekic , Doknic Mirjana , Miljic Dragana , Djurovic Marina Nikolic , Stojanovic Marko , Popovic Vera

Patients with hypopitutarism have higher cardiovascular morbidity and mortality rates than general population, as manifested by elevated fasting lipids and insulin resistance. The aim of our study was to evaluate the lipid levels and insulin responses during oral glucose tolerance test (OGTT) in adult onset growth hormone deficiency (AO-GHD), without growth hormone replacement during a follow-up period of seven years. Ten hypopituitary patients with operated non-functioning pi...

ea0016p590 | Paediatric endocrinology | ECE2008

Increased hyperinsulinism and insulin resistance, and decreased antioxidant defense, in children and adolescents with pre-metabolic versus metabolic syndromes

Dimitrijevic-Sreckovic Vesna , Sreckovic Branko , Colak Emina , Djordjevic Predrag , Canovic Fadil , Vukosavljevic Dragana , Stojanovic Jecka

Background and aims: The aim was to analyze insulin resistance (IR), glycoregulation disorders, lipid status, C-reactive protein (CRP), plasminogen activator inhibitor (PAI-1) and antioxidant defense in children and adolescents with pre-metabolic (Pre-MS) and metabolic (MS) syndromes.Material and methods: The study included 30 obese individuals (age 10–20 years, body mass index (BMI) or waist circumference (WC) ≥90 percentile). Three of the fo...

ea0016p773 | Thyroid | ECE2008

Surprising: hyperlipidemia in subclinical hyperthyroidism!

Marina Ljiljana , Vujovic Svetlana , Ivovic Miomira , Tancic-Gajic Milina , Stojanovic Milos , Barac Marija , Drezgic Milka

Subclinical hyperthyroidism is a biochemical diagnosis defined with suppressed levels of TSH and normal levels of thyroid hormones. One of the main metabolic responses to thyroid hyperfunction is peripheral lipolysis and release of free fatty acids (FFA). The aim of this study was to compare levels of cholesterol, LDL, HDL and triglycerides in persons with subclinical hyperthyroidism to age and BMI matched euthyroid healthy control. We evaluated 45 persons in two groups: 1st g...

ea0016p787 | Thyroid | ECE2008

Should we look for metabolic syndrome (MSy) in subclinical hypothyroidism?

Drezgic Milka , Marina Ljiljana , Ivovic Miomira , Tancic-Gajic Milina , Stojanovic Milos , Barac Marija , Vujovic Svetlana

Subclinical hypothyroidism is a biochemical diagnosis defined with elevated levels of TSH and normal levels of thyroid hormones. The most common abnormality linked to this condition is hypercholesterolemia. The aim of this study was to search for MSy among the persons with subclinical hypothyroidism which was already proven to have hypercholesterolemia when compared to healthy control. MSy was identified in those with elevated triglycerides (Tgc), reduced HDL and elevated fast...

ea0014p106 | (1) | ECE2007

Characteristics of metabolic syndrome in patients with adrenal incidentaloma

Ivovic Miomira , Vujovic Svetlana , Stojanovic Milos , Tancic-Gajic Milina , Marina Ljiljana , Barac Marija , Drezgic Milka

Several studies show that characteristics of metabolic syndrome are often seen in patients with adrenal incidentaloma. The aim of our study was to evaluate metabolic factors in these patients. 208 patients (148 female and 60 male, age 55.08±11.02 y’s and BMI 27.91±4.6 kg/m2) were admitted and biochemical, endocrine testing were performed. Lipid status: cholesterol 5.77±1.26 mmol/L, triglyceride 1.92±0.98 mmol/L. 113(55%) patients were hypert...

ea0014p209 | (1) | ECE2007

Influence of gaining weight on metabolic syndrome in the menopause

Simoncig-Netjasov Aleksandra , Vujovic Svetlana , Stojanovic Milos , Ivovic Miomira , Tancic Milina , Drezgic Milka

Metabolic syndrome (MS) represents a prominent risk factor for cardiovascular disease. Parameters of MS were compared between obese women and controls. I: 50 women (31.92±5.83 kg/m2; 54.4±3.64 y’s); Controls: 37 women (23.50±2.13 kg/m2; 53.92±3.95 y’s). Weight, height, waist and hips circumference, sagital abdominal diameter (SAD) and blood pressure (BP) were measured. Blood was taken at 8 am for: fasting glucose, triglycerid...

ea0014p473 | (1) | ECE2007

Bloch-sulzberger syndrome, hypothyroidism and a pituitary incidentaloma: a case report

Stojanovic Marko , Miljic Dragana , Doknic Mirjana , Djurovic Marina , Pekic Sandra , Nikolic Milos , Popovic Vera

A female patient, 34 years old, was referred to endocrinologist, for an incidentally discovered interstellar mass on MR, mild subclinical hypothyroidism and hyperprolactinemia, and irregular menstrual cycles. She was diagnosed with Bloch-Sulzberger syndrome (BSS) in neonatal age. Epilepsy, her most prominent component of BSS, was well controlled but only with triple anticonvulsant therapy (Valproate, Carbamazepine, Clonazepam). She was obese, clinically euthyroid, and exhibite...

ea0014p644 | (1) | ECE2007

Atherogenic indexes in women with premature ovarian failure-POF

Marina Ljiljana , Vujovic Svetlana , Ivovic Miomira , Stojanovic Milos , Tancic-Gajic Milina , Barac Marija , Drezgic Milka

POF is a disease of unclear origin affecting women under age 40. They are at high risk of cardiovascular diseases (CVD).The objective of this study was to compare the lipid status and atherogenic indexes - total cholesterol/high density lipoprotein (TC/HDL) and low density lipoprotein/HDL (LDL/HDL) - of women with POF with healthy women of the same age and the same BMI.We evaluated 54 women in two groups. 1st group: 31 women with P...

ea0011p505 | Endocrine tumours and neoplasia | ECE2006

Chromogranin-A in adrenal incidentalomas – marker for tumour secretion

Ivovic M , Penezic Z , Vujovic S , Marina Lj , Stojanovic M , Drezgic M

Adrenal incidentalomas are incidentally discovered adrenal tumors by imaging methods without any prior suspicions of adrenal disease. Most of these tumors are functionally inactive but thorough investigations can reveal discrete hormone excess. Chromogranin A(CgA) is expressed in neuroendocrine cells throughout the body, including large and small intestine, adrenal medulla and pancreatic islets. It is a marker for carcinoid tumors, paragangliomas, and other neuroendocrine tumo...